Idiopathic Pulmonary Fibrosis - 25 Studies Found
| RECRUITING |
: Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). : Idiopathic Pulmonary Fibrosis : 2024-11-21 : Nitric oxide gas for inhalation |
| COMPLETED |
: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF : Idiopathic Pulmonary Fibrosis : 2024-11-21 : Intravenous administration of a starting dose of the monoclonal antibody |
| COMPLETED |
: Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER : Idiopathic Pulmonary Fibrosis With Acute Exacerbation : 2024-11-21 : Steroid administration with routine dose - Methylprednisolone 1 mg/kg 7 days ? 0.5 mg/kg 7 days ? 0.25 mg kg 7 days |
| COMPLETED |
: Study Evaluating INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF) : Idiopathic Pulmonary Fibrosis (IPF) : 2024-11-21 : Pharmaceutical formulation: CapsulesMode of Administration: Oral |
| COMPLETED |
: Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis : Idiopathic Pulmonary Fibrosis, Acute Fatal Form : 2024-11-21 : TPE x 9, rituximab x 2, IVIG x 4. See arm/group descriptions for additional details. |